All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @vncezay on TikTok · 202s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @vncezay's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00So I'm a trans guy that currently takes taster gel.
  2. 0:03And today I sort of wanted to make an informative video
  3. 0:06on what to expect when being on Lodo's tea.
  4. 0:10To give a hint, there has been two changes
  5. 0:12that have been noticeable, despite being on Lodo's tea.
  6. 0:16So let's get on into them right now.
  7. 0:18Starting with the first change, bottom growth.
  8. 0:21Now I swear bro, I thought people were a cop
  9. 0:24in when they mentioned this, but it actually is true.
  10. 0:28And the reason why I figured this to become true
  11. 0:31is during, I think it was maybe my second or third month
  12. 0:35on taster gel.
  13. 0:36I noticed peeing down there.
  14. 0:38And without going into context too much,
  15. 0:42it does come to a point where you actually have
  16. 0:44to really clean down there good,
  17. 0:47because stuff starts to build up.
  18. 0:49I don't know why the testosterone makes things
  19. 0:53build up down there, but hygiene starts to become
  20. 0:57really big importance.
  21. 0:59Not that I don't clean myself.
  22. 1:01I short every day.
  23. 1:02It's just, I did not know that you kind of had to like
  24. 1:06pull the thing back, you know what I mean?
  25. 1:08But I think this is a bit TMI, so I'm gonna stop right here.
  26. 1:12In terms of the second noticeable change on Lodo's tea,
  27. 1:16a lot of people have been point in point in point.
  28. 1:19I have kind of like a mustache going on here.
  29. 1:23Now this has only came up during my fourth month.
  30. 1:26So this is kind of new to me, though I've always had
  31. 1:30little dark chin hairs that are similar to facial hairs.
  32. 1:35I don't know if any of you can see it,
  33. 1:37but I promise you it is there.
  34. 1:41I might have to take a photo though.
  35. 1:43Besides for that, that is pretty much the only changes
  36. 1:47I personally have experienced on Lodo's tea.
  37. 1:50Now before I get comments on my voice,
  38. 1:52because I know a lot of people bring it up,
  39. 1:55what about your voice?
  40. 1:57A lot of people tell me it's very possible
  41. 1:59and they think T has contributed to this,
  42. 2:03but I've always had this voice since pre-tee,
  43. 2:07so I just wanna point that out.
  44. 2:09As I've had professionals compliment me on it,
  45. 2:12but not only that, you guys in the comments too.
  46. 2:15The reason I just think it's important to mention
  47. 2:18is I wanna give a clear accurate representation
  48. 2:22of the changes to expect on Lodo's tea
  49. 2:25and voice in my case just has not been one of them.
  50. 2:30I don't think my voice will change
  51. 2:33until I start my new dose, which makes sense
  52. 2:36because my levels right now are low,
  53. 2:39but that makes sense because why would the voice change
  54. 2:42if your levels are low?
  55. 2:45So I'm hoping that when I start my new dose,
  56. 2:48that will put my testosterone levels into range
  57. 2:51and then I'll start actually noticing
  58. 2:54something happening within my vocal cords,
  59. 2:56which will be kinda cool.
  60. 2:58But yeah, man, that's pretty much everything I've noticed.
  61. 3:01Drop a comment down below
  62. 3:03and let me know what type of changes you notice
  63. 3:06when you were on Lodo's tea
  64. 3:08or if you haven't started tea yet,
  65. 3:10what changes you're the most excited to look forward to.
  66. 3:13If you wanna stay up to date on my journey,
  67. 3:15feel free to click the little plus,
  68. 3:17should be right there.
  69. 3:19And I'll see you all in the next of the piece.

@vncezay's testogel transition claims, fact-checked

VNCEZAY

TikTok creator

7.5K viewsWatch on TikTok

Quick answer

The creator is a trans man four months into low-dose Testogel therapy, reporting clitoral growth and early facial hair as the primary changes observed, with no notable voice change attributed to sub-therapeutic serum testosterone levels. Both reported effects are consistent with known early androgen responses documented in gender-affirming hormone therapy literature, though voice change onset is more variable and not strictly gated by reaching a target serum range. Monitoring testosterone levels, hematocrit, and lipid panels at regular intervals is standard of care during testosterone therapy regardless of dose.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @vncezay's testogel transition claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@vncezay's testogel transition claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@vncezay's testogel transition claims, fact-checked" from VNCEZAY. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is a trans man four months into low-dose Testogel therapy, reporting clitoral growth and early facial hair as the primary changes observed, with no notable voice change attributed to sub-therapeutic serum testosterone levels.

The reason this review is not generic is the source wording and the canonical claim label "trt 4 months on low dose t testogel changes testogel ftm t." In this clip, the useful excerpt is: "So I'm a trans guy that currently takes taster gel." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Facial hair onset typically falls between months three and six per the ENIGI cohort study (Klaver et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is a trans man four months into low-dose Testogel therapy, reporting clitoral growth and early facial hair as the primary changes observed, with no notable voice change attributed to sub-therapeutic serum testosterone levels.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is a trans man four months into low-dose Testogel therapy, reporting clitoral growth and early facial hair as the primary changes observed, with no notable voice change attributed to sub-therapeutic serum testosterone levels. Both reported effects are consistent with known early androgen responses documented in gender-affirming hormone therapy literature, though voice change onset is more variable and not strictly gated by reaching a target serum range. Monitoring testosterone levels, hematocrit, and lipid panels at regular intervals is standard of care during testosterone therapy regardless of dose.
  • Clitoral growth is one of the earliest documented effects of testosterone therapy, reported in nearly all trans men in the Wierckx et al. 2014 study, often within the first one to three months.
  • Facial hair onset typically falls between months three and six per the ENIGI cohort study (Klaver et al., 2018), making month-four mustache growth a realistic and expected finding.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Clitoral growth is one of the earliest documented effects of testosterone therapy, reported in nearly all trans men in the Wierckx et al. 2014 study, often within the first one to three months.
  • Facial hair onset typically falls between months three and six per the ENIGI cohort study (Klaver et al., 2018), making month-four mustache growth a realistic and expected finding.
  • Voice change is a gradient process driven by cumulative androgen exposure, not a switch that flips once serum testosterone hits a reference range, so the creator's framing here is an oversimplification.
  • Testogel is a transdermal testosterone gel with documented transfer risk to others through skin contact, which is a safety consideration not mentioned in the video but relevant for anyone in close physical contact with children or partners.
  • The Endocrine Society's 2017 Clinical Practice Guidelines recommend individualized testosterone dosing with regular monitoring of serum testosterone, hematocrit, and lipid panels, not a fixed low-dose protocol for everyone.
  • Low-dose testosterone therapy is used intentionally in some cases for partial masculinization, but effect timelines are longer and less pronounced compared to standard dosing, and genetic factors significantly influence individual response.
  • Absorption of Testogel varies between individuals based on skin condition, application site, and body composition, meaning two people on the same labeled dose may have meaningfully different serum testosterone levels.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @vncezay actually say?

@vncezay is a trans man four months into low-dose testosterone gel (Testogel) and wanted to give an honest rundown of what's actually changed. Two things: clitoral growth (what's often called "bottom growth" in trans masc communities) and the early appearance of facial hair, specifically a mustache forming in month four. They also pushed back on the idea that their voice has changed on T, saying they've always had a lower voice pre-T, and attributed the lack of voice change to still being on a low dose with levels outside the typical range.

This is a personal experience video, not a medical guide, and @vncezay frames it that way. They're not telling anyone what to take or how much. That matters when evaluating what they got right and wrong.

Does the science back this up?

Mostly, yes. The two changes they describe, clitoral growth and early facial hair, are well-documented early effects of testosterone in trans men, even at lower doses. The hygiene point around clitoral growth is less talked about in clinical literature but is consistent with reported patient experiences.

Clitoral growth (clitoromegaly) is one of the earliest and most consistent effects of testosterone therapy in transgender men. A 2014 study by Wierckx et al. in the Journal of Sexual Medicine found that clitoral growth was reported by nearly all trans men within the first few months of testosterone therapy, often beginning within weeks. The structural changes relate to androgen receptor density in genital tissue, which is high relative to other tissues.

Facial hair onset is slower and more variable. The landmark ENIGI study (Klaver et al., 2018, Journal of Sexual Medicine) found that facial hair typically begins appearing between months three and six of testosterone therapy, which lines up with @vncezay's month-four mustache. Voice changes, by contrast, tend to lag behind and correlate more closely with total testosterone exposure over time, not just dosage at any single point.

What did they get wrong (or right)?

They got the core biology right. But one claim deserves scrutiny: the idea that voice won't change until testosterone levels are "in range." That's an oversimplification.

Voice changes in trans men are driven by cumulative androgen exposure and laryngeal cartilage response, not simply by whether serum testosterone sits within a reference range on any given lab draw. Research by Nygren et al. (2016, Journal of Voice) found that voice changes in trans men are progressive and can begin at sub-therapeutic levels, though they're more pronounced and faster with higher levels. Saying voice change is gated entirely by hitting a target range treats a gradient biological process like a binary switch. It's not accurate.

The hygiene note around bottom growth is anecdotally reported by trans men and is consistent with the anatomical changes, but there's limited peer-reviewed literature on this specific point. It's not wrong, but it's not clinically established either.

Overall, @vncezay is more careful and accurate than a lot of T-content creators. They're not overpromising timelines or making up mechanisms.

What should you actually know?

If you're considering testosterone therapy, either for gender-affirming purposes or hypogonadism, the timeline and magnitude of changes vary significantly between individuals. Dose matters, but so do genetics, baseline hormone levels, age, and how your body metabolizes androgens.

Low-dose testosterone is sometimes used intentionally, particularly in non-binary or gender-fluid individuals who want partial masculinization. It's also used as a starting point before titrating up. The Endocrine Society's 2017 Clinical Practice Guidelines for gender-dysphoric individuals recommend individualized dosing with regular monitoring of serum testosterone, hematocrit, and lipids, not a one-size approach.

Testogel specifically delivers testosterone transdermally, and absorption varies based on application site, skin condition, and body composition. Transfer risk to others through skin contact is real and documented, which is a relevant safety point for anyone sharing living space or physical contact with others, particularly children.

Bottom growth and early facial hair are realistic early expectations. Significant voice change, muscle redistribution, and fat redistribution typically take longer and correlate more with sustained adequate testosterone levels over months to years.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

VNCEZAY · TikTok creator

7.5K views on this video

4 Months On Low Dose T / Testogel Changes! #testogel #ftm #transguy #ftmtransition #🏳️‍⚧️

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about clitoral growth?

Clitoral growth is one of the earliest documented effects of testosterone therapy, reported in nearly all trans men in the Wierckx et al. 2014 study, often within the first one to three months.

What does the video say about facial hair onset typically falls between months three?

Facial hair onset typically falls between months three and six per the ENIGI cohort study (Klaver et al., 2018), making month-four mustache growth a realistic and expected finding.

What does the video say about voice change?

Voice change is a gradient process driven by cumulative androgen exposure, not a switch that flips once serum testosterone hits a reference range, so the creator's framing here is an oversimplification.

What does the video say about testogel?

Testogel is a transdermal testosterone gel with documented transfer risk to others through skin contact, which is a safety consideration not mentioned in the video but relevant for anyone in close physical contact with children or partners.

What does the video say about the endocrine society's 2017 clinical practice guidelines recommend individualized testosterone?

The Endocrine Society's 2017 Clinical Practice Guidelines recommend individualized testosterone dosing with regular monitoring of serum testosterone, hematocrit, and lipid panels, not a fixed low-dose protocol for everyone.

What does the video say about low-dose testosterone therapy?

Low-dose testosterone therapy is used intentionally in some cases for partial masculinization, but effect timelines are longer and less pronounced compared to standard dosing, and genetic factors significantly influence individual response.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by VNCEZAY, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.